WebMar 30, 2024 · This is a prospective, open-label, single-arm clinical trial. The aim of this study is to evaluate the efficacy and safety of almonertinib and intrathecal chemotherapy in patients with advanced EGFR mutation positive (EGFRm+) non-small cell lung cancer (NSCLC) and leptomeningeal metastasis, and to explore the predictive value of dynamic … WebControl hypertension and correct hypokalemia before treatment. Monitor blood pressure, serum potassium and symptoms of fluid retention at least monthly. ... The median time to initiation of chemotherapy was not reached for patients on abiraterone acetate with prednisone and was 38.9 months for patients on placebos (HR = 0.44; 95% CI: [0.35, 0. ...
Cancer Treatment–Induced Arrhythmias Circulation: Arrhythmia …
WebJun 1, 2006 · I ntroduction. Methotrexate (MTX), a classical antifolate, is one of the most widely used and studied anticancer agents [1–4].Unlike other anticancer agents, MTX can be safely administered over a wide … WebJul 18, 2024 · Hypomagnesemia secondary to chemotherapy has long been recognized with the use of platinum‐containing drugs (cisplatin, carboplatin, and oxaliplatin) that are used for a variety of solid cancers (e.g. lung cancer, head and neck cancer, and cervical cancer). 77, 78 It is most common with cisplatin, a drug that was approved by the Food … impact fellowship penn state harrisburg
These highlights do not include all the information needed to use ...
WebFinally, several chemotherapy drugs have been linked to hyponatremia via potentiation of ADH release or action, in-cluding vinblastine, vincristine, and cyclophosphamide (7). … WebMar 5, 2014 · Chemotherapy with cisplatin is known to cause hypokalemia and hypomagnesemia with metabolic alkalosis as a possible complication [5, 6]. Cisplatin is a coordinate metal complex with significant antineoplastic activity, and its side effects include acute and chronic renal insufficiency, renal magnesium wasting and electrolyte … WebApr 1, 2024 · Of importance, hypokalemia is uncommon in glucocorticoid-remediable aldosteronism, and when it occurs, it is usually triggered by a potassium-wasting diuretic agent. 2,11. ... Weeks later, he was readmitted to start chemotherapy and received etoposide and carboplatin. Because the cancer was advanced and unresectable, … list shape in visio